GSA Capital Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.35M | Sell |
|
|||||
|
2025
Q2 | $1.52M | Sell |
|
|||||
|
2025
Q1 | $1.63M | Buy |
|
|||||
|
2024
Q4 | $1.53M | Sell |
|
|||||
|
2024
Q3 | $1.85M | Buy |
|
|||||
|
2024
Q2 | $1.73M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $866K | Sell |
|
|||||
|
2023
Q3 | $2.81M | Buy |
|
|||||
|
2023
Q2 | $206K | Sell |
|
|||||
|
2023
Q1 | $1.14M | Buy |
|
|||||
|
2022
Q4 | $646K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.04M | Buy |
|
|||||
|
2022
Q1 | $473K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $206K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $209K | Buy |
|